I think its characteristics can certainly increase the relief, because of the different mechanisms, it is B cell suppression, mainly cellular immunosuppression, we originally used basically body fluid immune suppression, T cell suppression. This point is inhibited from the beginning of B cells, mainly on the activation of B cells in the complement activation pathway has very great benefits, because lupus is also a disease of the complement activation pathway, so feel that the treatment of this pathway is more targeted at the patient activation of immune cells the most fundamental inhibition, so I think the potential benefits are very much, from this point is a very targeted treatment.
正在翻译中..